跳至主要内容
临床试验/NCT06181552
NCT06181552尚未招募不适用

Development of Cardiovascular Risk Prediction Tools Based on Artificial Intelligence and Fundus Imaging Technology Study

China National Center for Cardiovascular Diseases0 个研究点目标入组 1,072 人开始时间: 2023年12月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
1,072
主要终点
Diagnosis of ASCVD at baseline

研究概览

简要总结

This study aims to develop a cardiovascular disease (CVD) screening tool and cardiovascular risk prediction tool based on fundus imaging data with the method of artificial intelligence.

详细描述

This study will establish a cohort of individuals including patients with CVD and participants with high CVD risk, and all the study participants will be follow-up for 1 year. By collecting baseline clinical data, fundus imaging data, and CVD events during the follow up, this study aims to distinguish CVD status based on the fundus imaging data, and explore the association between fundus imaging data and occurence of CVD during the follow up. By using machine learning approach, this study aims to construct a CVD screening tool and CVD prediction tool based on fundus imaging data.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Three types of participants will be included, which are:
  • Participants with established coronary heart disease, including previously diagnosed myocardial infarction, previous treatment with coronary intervention or coronary artery bypass grafting, coronary artery stenosis ≥50%, or chest pain with objective evidence of myocardial ischemia (myocardial ischemia indicated by stress electrocardiogram or stress imaging)
  • Participants with established stroke.
  • Participants without coronary heart disease or stroke, but are at high risk for CVD, defined as meeting at least two of the following:
  • Men aged ≥ 60 years old, or women aged ≥ 65 years old;
  • Total cholesterol>5.2 mmol/L, or LDL-C>3.4 mmol/L, or HDL-C<1.0 mmol/L;
  • Currently smoking, defined as daily smoking lasting for 1 year or more.

排除标准

  • Participants unable to provide fundus imaging data required for the study due to the following reasons:
  • Permanent blindness, blurred vision, flying mosquito disease, or refractive medium opacity seriously affecting fundus examination, such as severe cataracts, vitreous hemorrhage, etc.
  • Macular edema, severe nonproliferative retinopathy in diabetes, proliferative vitreoretinopathy, radiation ophthalmopathy or retinal vein occlusion
  • Eyeball enucleation, eye deformities, etc.
  • Previous retinal laser therapy, injection therapy for any eye, or history of retinal surgery
  • Photosensitivity, or taking medication that can cause photosensitivity, or currently undergoing photodynamic therapy
  • Unable to cooperate with examination for collection of fundus imaging data
  • Other situations that the participants fail to provide fundus imaging data required for the study
  • Suffering from other serious diseases with an expected survival period of less than one year, such as advanced malignant tumors
  • Unable to adhere to follow-up
  • Other conditions which the researchers consider inappropriate for participants to enroll in the study

结局指标

主要结局

Diagnosis of ASCVD at baseline

时间窗: At enrollment

Whether participants have established ASCVD at baseline

Major cardiovascular events

时间窗: during the 1 year follow-up

a composite of myocardial infarction, coronary or non coronary revascularization surgery, hospitalization or emergency treatment due to new-onset or worsening heart failure, stroke or cardiovascular death

次要结局

未报告次要终点

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Sponsor

相似试验